Previous Article | Next Article ![]()
Infection and Immunity, August 2006, p. 4918-4921, Vol. 74, No. 8
0019-9567/06/$08.00+0 doi:10.1128/IAI.00258-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Antimicrobial Research Centre, Department of Biochemistry and Biomedical Sciences, McMaster University, 1200 Main Street West, Hamilton, Ontario, Canada L8N 3Z5,1 Department of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada N6A 5C12
Received 16 February 2006/ Returned for modification 27 April 2006/ Accepted 9 May 2006
Gene products required for in vivo growth and survival of Staphylococcus aureus and other pathogens represent new targets for antimicrobial chemotherapy. In this study we created a Staphylococcus aureus yjeQ deletion strain and tested its virulence using a mouse kidney abscess infection model. The yjeQ deletion strain was compromised for growth in vitro and severely attenuated for virulence. We concluded that yjeQ is an attractive and novel new drug target.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»